Loading
journalsJournal
JCO global oncology
ASCO's open access journal for cancer care and research in low- and middle-income countries and other resource-limited settings. Read by oncologists and public-health researchers working on cancer worldwide.
Also called: JCO Glob OncolJCO GOJournal of Global Oncology
Overview
JCO Global Oncology is published by the American Society of Clinical Oncology in the United States. NLM records that it continues the Journal of Global Oncology (ISSN 2378-9506), that some volume 6 articles appeared electronically in 2019, and that articles are published as they are accepted and compiled into annual volumes. The Directory of Open Access Journals lists it as a fully open access journal from 2020 with anonymous peer review, an article processing charge, and articles published under CC BY or CC BY-NC-ND licences. Indexed for MEDLINE under Medical Oncology and Neoplasms.
Publisher
American Society of Clinical Oncology · American Society of Clinical Oncology
Scope
global oncology
Website
Access model
open access
Founded
2019
ISSN
2687-8941
rct20260 citations
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS)
One trial page and one institution page on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observational20251 citation
Genomic profiling of Indian gallbladder carcinoma: mutational insights in a high-incidence population
HER2 is as frequent in India as in the West, so HER2 testing pays off in the highest-incidence population, while tumour-agnostic immunotherapy markers will rarely apply. The paper also shows plasma testing is feasible where tissue is scarce.
observational20245 citations
Clinical and genomic characterization of ERBB2-altered gallbladder cancer: exploring differences between an American and a Chilean cohort
The cleanest split of HER2 alterations in gallbladder cancer into amplification and mutation, which matters because IHC and ISH only see the amplified tumours. It also shows the high-incidence Chilean population has not been sequenced at scale.
observational2020552 citations
Cancer Statistics, 2020: Report from National Cancer Registry Programme, India
India's cancer problem is a late-diagnosis problem as much as a treatment problem: the same cancers that dominate (oral, cervical, breast) are the ones screening and vaccination can prevent or catch early. The numbers set the priorities of the National Cancer Grid, PM-JAY oncology packages and the national screening programme.
Adda Bounedjar
Representative of Anti-Cancer Center of Blida to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Adda Bounedjar represents Anti-Cancer Center of Blida in the Organisation of European Cancer Institutes, which lists the organisation among its members in Algeria.
Akhil Kapoor
Medical oncologist, Homi Bhabha Cancer Hospital and MPMMCC, Varanasi (Tata Memorial Centre)
Head and neck cancerMetronomic chemotherapyPragmatic trials
First author of METRO PLUS, the Varanasi trial that doubled survival in advanced head and neck cancer by adding cheap oral metronomic drugs to standard chemotherapy.
Asem Mansour
CEO and Director General
RadiologyCancer centre leadershipOncology services in the Middle East
Radiologist who leads the King Hussein Cancer Center in Amman, the leading comprehensive cancer centre in Jordan and the region.
Diwani Msemo
Executive Director, Ocean Road Cancer Institute
Cancer services in TanzaniaRadiotherapy accessHealth system leadership
Executive Director of the Ocean Road Cancer Institute, Tanzania's national cancer hospital in Dar es Salaam.
Mauricio Cuello
Director, Instituto Nacional del Cáncer (Uruguay)
OncologyHospital management
Physician listed as Director of Uruguay's Instituto Nacional del Cáncer, the national oncology reference hospital in Montevideo run by ASSE.
Prashant Mathur
Director, ICMR-National Institute of Noncommunicable Disease Epidemiology (formerly NCDIR), Bengaluru
Cancer registriesCancer epidemiologyNoncommunicable disease surveillance
Directs the institute that runs India's cancer registries and is first author of the national report estimating 1.39 million new cancers in 2020.
Susan Love
Breast surgeon, author and founder of the Army of Women
Breast surgeryBreast cancer preventionPatient education
Her Breast Book gave women the information to question their surgeons; she co-founded the National Breast Cancer Coalition and in 2008 recruited hundreds of thousands of women into research through the Army of Women.
rctJCO global oncology 20260 citations
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS)
One trial page and one institution page on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
observationalJCO Global Oncology 2020552 citations
Cancer Statistics, 2020: Report from National Cancer Registry Programme, India
India's cancer problem is a late-diagnosis problem as much as a treatment problem: the same cancers that dominate (oral, cervical, breast) are the ones screening and vaccination can prevent or catch early. The numbers set the priorities of the National Cancer Grid, PM-JAY oncology packages and the national screening programme.